Minnal Gupta

7.5k total citations
9 papers, 309 citations indexed

About

Minnal Gupta is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Minnal Gupta has authored 9 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Minnal Gupta's work include CAR-T cell therapy research (8 papers), Virus-based gene therapy research (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Minnal Gupta is often cited by papers focused on CAR-T cell therapy research (8 papers), Virus-based gene therapy research (3 papers) and Acute Lymphoblastic Leukemia research (2 papers). Minnal Gupta collaborates with scholars based in United States. Minnal Gupta's co-authors include Simon F. Lacey, J. Joseph Melenhorst, Carl H. June, Bruce L. Levine, Irina Kulikovskaya, Vanessa Gonzalez, Gabriela Plesa, Noelle V. Frey, Katherine T. Marcucci and David L. Porter and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Minnal Gupta

9 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minnal Gupta United States 7 255 114 97 84 73 9 309
Claudia Diamonte United States 10 322 1.3× 108 0.9× 73 0.8× 79 0.9× 84 1.2× 18 353
Aleksei Titov Russia 7 214 0.8× 70 0.6× 122 1.3× 147 1.8× 61 0.8× 13 368
Sean C. Dougherty United States 5 292 1.1× 80 0.7× 118 1.2× 126 1.5× 68 0.9× 14 341
Paul Castillo United States 9 331 1.3× 100 0.9× 130 1.3× 154 1.8× 130 1.8× 34 462
Ruimin Hong China 9 283 1.1× 72 0.6× 127 1.3× 75 0.9× 60 0.8× 29 355
Deanna Langfitt United States 8 246 1.0× 71 0.6× 117 1.2× 117 1.4× 75 1.0× 15 315
Angela Hückelhoven‐Krauss Germany 13 333 1.3× 120 1.1× 131 1.4× 111 1.3× 112 1.5× 26 403
Miriam Sánchez‐Escamilla Spain 5 193 0.8× 72 0.6× 56 0.6× 66 0.8× 50 0.7× 13 239
Edward Waldron United States 5 291 1.1× 73 0.6× 160 1.6× 63 0.8× 64 0.9× 13 362
Vania Baldan United Kingdom 6 294 1.2× 72 0.6× 109 1.1× 144 1.7× 83 1.1× 9 360

Countries citing papers authored by Minnal Gupta

Since Specialization
Citations

This map shows the geographic impact of Minnal Gupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minnal Gupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minnal Gupta more than expected).

Fields of papers citing papers by Minnal Gupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minnal Gupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minnal Gupta. The network helps show where Minnal Gupta may publish in the future.

Co-authorship network of co-authors of Minnal Gupta

This figure shows the co-authorship network connecting the top 25 collaborators of Minnal Gupta. A scholar is included among the top collaborators of Minnal Gupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minnal Gupta. Minnal Gupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Tang, Oliver Y., Lifeng Tian, Rong Xu, et al.. (2022). PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical Response. Frontiers in Immunology. 13. 872756–872756. 22 indexed citations
2.
Panjwani, M. Kazim, Matthew J. Atherton, Kumudhini Preethi Haran, et al.. (2019). Establishing a model system for evaluating CAR T cell therapy using dogs with spontaneous diffuse large B cell lymphoma. OncoImmunology. 9(1). 1676615–1676615. 41 indexed citations
3.
Melenhorst, J. Joseph, David Porter, Lifeng Tian, et al.. (2018). Long-Term Remission of CLL Sustained By Pauciclonal Anti-CD19 Chimeric Antigen Receptor T (CTL019) Cell Clones. Blood. 132(Supplement 1). 699–699. 3 indexed citations
4.
Marcucci, Katherine T., Julie K. Jadlowsky, Wei‐Ting Hwang, et al.. (2017). Retroviral and Lentiviral Safety Analysis of Gene-Modified T Cell Products and Infused HIV and Oncology Patients. Molecular Therapy. 26(1). 269–279. 91 indexed citations
5.
Maude, Shannon L., George Hucks, Alix E. Seif, et al.. (2017). The effect of pembrolizumab in combination with CD19-targeted chimeric antigen receptor (CAR) T cells in relapsed acute lymphoblastic leukemia (ALL).. Journal of Clinical Oncology. 35(15_suppl). 103–103. 79 indexed citations
6.
O’Rourke, Donald M., Fang Chen, Zev A. Binder, et al.. (2017). Abstract LB-053: Next-generation sequencing of T-cell receptor-beta gene rearrangements reveals dramatic expansion of T-cell clonotypes after CART-EGFRvIII therapy for glioblastoma. Cancer Research. 77(13_Supplement). LB–53. 1 indexed citations
7.
Elenitsas, Rosalie, Laura A. Taylor, Simon F. Lacey, et al.. (2016). Evaluating the skin in patients undergoing chimeric antigen receptor modified T-cell therapy. Journal of the American Academy of Dermatology. 75(5). 1054–1057. 18 indexed citations
8.
Garfall, Alfred L., Eric Lancaster, Edward A. Stadtmauer, et al.. (2016). Posterior Reversible Encephalopathy Syndrome (PRES) after Infusion of Anti-Bcma CAR T Cells (CART-BCMA) for Multiple Myeloma: Successful Treatment with Cyclophosphamide. Blood. 128(22). 5702–5702. 36 indexed citations
9.
Kalos, Michael, Farzana Nazimuddin, Jeffrey Finklestein, et al.. (2013). Long-Term Functional Persistence, B Cell Aplasia and Anti-Leukemia Efficacy In Refractory B Cell Malignancies Following T Cell Immunotherapy Using CAR-Redirected T Cells Targeting CD19. Blood. 122(21). 163–163. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia Diamonte Breakdown of academic impact, for papers by Aleksei Titov Breakdown of academic impact, for papers by Sean C. Dougherty Breakdown of academic impact, for papers by Paul Castillo Breakdown of academic impact, for papers by Ruimin Hong Breakdown of academic impact, for papers by Deanna Langfitt Breakdown of academic impact, for papers by Angela Hückelhoven‐Krauss Breakdown of academic impact, for papers by Miriam Sánchez‐Escamilla Breakdown of academic impact, for papers by Edward Waldron Breakdown of academic impact, for papers by Vania Baldan
Rankless by CCL
2026